相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophage-Targeted Isoniazid-Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli
Jiang Pi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
Caleb F. Anderson et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation
Yun Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Folate-conjugated nanovehicles: Strategies for cancer therapy
Batoul Farran et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Grand challenges in nanomedicine
Lin-Ping Wu et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle-Cell Interactions
Nils-Jorgen Knudsen Dal et al.
SMALL (2020)
Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases
Gauthami Pulivendala et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Phagocytosis: Phenotypically Simple Yet a Mechanistically Complex Process Phagocytosis is a very complex but crucial process playing a pivotal role in embryonic development and host defense to maintain immune homeostasis
Vijay Kumar
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2020)
Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin
Jiri Trousil et al.
JOURNAL OF CONTROLLED RELEASE (2020)
ATTACHED, DETACHED and WITHOUT inhaler technique coaching tools to optimize pMDI use competence, asthma control and quality-of-life in asthmatic adults
Wesam G. Ammari et al.
JOURNAL OF THORACIC DISEASE (2020)
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?
Eleonora Truzzi et al.
NANOMATERIALS (2020)
Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets — Worldwide, 2018
Adam MacNeil et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Recent advantage of hyaluronic acid for anti-cancer application: a review of 3S transition approach
Wei Zhong et al.
CARBOHYDRATE POLYMERS (2020)
Repetitive instructions at short intervals contribute to the improvement of inhalation technique
Rie Baba et al.
ASIA PACIFIC ALLERGY (2020)
Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in Zebrafish
Jiri Trousil et al.
BIOMACROMOLECULES (2019)
Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity
Simone Pinto Carneiro et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Enhanced antitubercular activity, alveolar deposition and macrophages uptake of mannosylated stable nanoliposomes
Amira Hamed et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis
Vanesa Andreu et al.
NANOMEDICINE (2019)
Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control
Afzal Hussain et al.
CURRENT DRUG DELIVERY (2019)
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection
Juan Manuel Coya et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Immunotherapeutic potential of an N-formylated peptide of Listeria monocytogenes in experimental tuberculosis
Shabir Ahmad Mir et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
Macrophage heterogeneity and plasticity in tuberculosis
Arshad Khan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M. tuberculosis killing efficiency
Jiang Pi et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Definitions and guidelines for research on antibiotic persistence
Nathalie Q. Balaban et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Jihye Yoo et al.
CANCERS (2019)
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections
Irene Rossi et al.
PHARMACEUTICS (2019)
Active Nano-targeting of Macrophages
Natasa Gaspar et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut
Tian-Hang Li et al.
GASTROENTEROLOGY REPORT (2019)
Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
Emanuele Pontali et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis
Sharif Abdelghany et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule
Farideh Shiehzadeh et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
Guorong Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications
Parveen Kumar et al.
PHARMACEUTICS (2019)
Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies
Mohammad A. M. Momin et al.
PHARMACEUTICS (2019)
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant
Eleonora Maretti et al.
PHARMACEUTICS (2019)
Development and biological evaluation of a new nanotheranostic for tuberculosis
Edward Helal-Neto et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Polymeric nanobiotics as a novel treatment for mycobacterial infections
Iris L. Batalha et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles
Yu Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Nanomedicines Lost in Translation
Keegan Guidolin et al.
ACS NANO (2019)
Polypeptidic Micelles Stabilized with Sodium Alginate Enhance the Activity of Encapsulated Bedaquiline
Hector Soria-Carrera et al.
MACROMOLECULAR BIOSCIENCE (2019)
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy
Eleonora Maretti et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Enhanced Delivery of 4-Thioureidoiminomethylpyridinium Perchlorate in Tuberculosis Models with IgG Functionalized Poly(Lactic Acid)-Based Particles
Leonid Churilov et al.
PHARMACEUTICS (2019)
Therapeutic efficacy of nanoparticles and routes of administration
Dhrisya Chenthamara et al.
BIOMATERIALS RESEARCH (2019)
Airway geometry, airway flow, and particle measurement methods: implications on pulmonary drug delivery
A. Kourmatzis et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections
Kaijin Xu et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Surface Layer Modification of Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate
Kata Horvati et al.
BIOCONJUGATE CHEMISTRY (2018)
New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules
L. De Matteis et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents
Sanjay Tiwari
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2018)
Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages
Ana Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Collaborating centres: Rediscovering an extended arm of World Health Organization
Poonam Khetrapal Singh
INDIAN JOURNAL OF MEDICAL RESEARCH (2018)
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer
Mirco Ponzoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation
Remi Rosiere et al.
MOLECULAR PHARMACEUTICS (2018)
Pursuing Intracellular Pathogens with Hyaluronan. From a 'Pro-Infection' Polymer to a Biomaterial for 'Trojan Horse' Systems
Elita Montanari et al.
MOLECULES (2018)
Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
Tian Zhou et al.
NANOMEDICINE (2018)
Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
Sujit Kumar Debnath et al.
PLOS ONE (2018)
Engineered nanomaterials and human health: Part 1. Preparation, functionalization and characterization (IUPAC Technical Report)
Vladimir Gubala et al.
PURE AND APPLIED CHEMISTRY (2018)
Targeted delivery of anti-tuberculosis drugs to macrophages: targeting mannose receptors
Lyubov Yu Filatova et al.
RUSSIAN CHEMICAL REVIEWS (2018)
Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma
Landon W. Locke et al.
TUBERCULOSIS (2018)
Advances in targeting the folate receptor in the treatment/imaging of cancers
Marcos Fernandez et al.
CHEMICAL SCIENCE (2018)
Development of Inhalable Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in Microparticulate System for Antituberculosis Drug Delivery
Margarida S. Miranda et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Inhalable Fucoidan Microparticles Combining Two Antitubercular Drugs with Potential Application in Pulmonary Tuberculosis Therapy
Ludmylla Cunha et al.
POLYMERS (2018)
Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages
Alexandre C. C. Vieira et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Smartly Engineered PEGylated Di-Block Nanopolymeric Micelles: Duo Delivery of Isoniazid and Rifampicin Against Mycobacterium tuberculosis
Sarita Rani et al.
AAPS PHARMSCITECH (2018)
Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse Models
Federico Fenaroli et al.
ACS NANO (2018)
Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches
Kamal Dua et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
Tejal Rawal et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead
Estefania Grotz et al.
PHARMACEUTICAL RESEARCH (2018)
The zebrafish model of tuberculosis - no lungs needed
Ghada Bouz et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2018)
Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future
Piyush Mehta et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
John P. A. Ioannidis et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Respiratory Tract Deposition and Distribution Pattern of Microparticles in Mice Using Different Pulmonary Delivery Techniques
Nitesh K. Kunda et al.
VACCINES (2018)
The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages
Julio M. Rios de la Rosa et al.
ADVANCED HEALTHCARE MATERIALS (2017)
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates
Zsuzsa Baranyai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery
Francesco Martinelli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases
Ha Young Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
Diana P. Gaspar et al.
MOLECULAR PHARMACEUTICS (2017)
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
Hui-Qiong He et al.
MOLECULES (2017)
Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
Dongfei Liu et al.
NANO LETTERS (2017)
Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment
Alexandre C. C. Vieira et al.
NANOMEDICINE (2017)
M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1
Murugesan V. S. Rajaram et al.
CELL REPORTS (2017)
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Joana Costa-Gouveia et al.
SCIENTIFIC REPORTS (2017)
Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us
Tracy L. Keiser et al.
MICROBIOLOGY SPECTRUM (2017)
Tuftsin - Properties and Analogs
Agnieszka Siebert et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Pulmonary drug delivery system: newer patents
Shahid Sukhbir Kaur
PHARMACEUTICAL PATENT ANALYST (2017)
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
Kifayatullah Shah et al.
DRUG DELIVERY (2017)
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
How can nanoparticles contribute to antituberculosis therapy?
Joana Costa-Gouveia et al.
DRUG DISCOVERY TODAY (2017)
Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2017)
Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish
Carina Beatrice Vibe et al.
NANOTOXICOLOGY (2016)
The formulation of nanomedicines for treating tuberculosis
Ana Costa et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Yuko Nakamura et al.
BIOCONJUGATE CHEMISTRY (2016)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment
Joao P. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis
Marina Pinheiro et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases
Colleen M. McClean et al.
PATHOGENS AND DISEASE (2016)
Granulomas and inflammation: Host-Directed Therapies for Tuberculosis
Hlumani Ndlovu et al.
FRONTIERS IN IMMUNOLOGY (2016)
Tuberculosis
Madhukar Pai et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases
Young-Su Yi
IMMUNE NETWORK (2016)
Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne
Tarun Garg
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles
Rohan Parmar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Targeted Drug Delivery Systems for Lung Macrophages
Ana Costa et al.
CURRENT DRUG TARGETS (2015)
Active Targeted Drug Delivery for Microbes Using Nano-Carriers
Yung-Sheng Lin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Hyaluronic Acid-Tocopherol Succinate-Based Self-Assembling Micelles for Targeted Delivery of Rifampicin to Alveolar Macrophages
Yuan Gao et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis
Yolandy Lemmer et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanocarrier-based interventions for the management of MDR/XDR-TB
Sanaul Mustafa et al.
JOURNAL OF DRUG TARGETING (2015)
Nanoparticle uptake: The phagocyte problem
Heather Herd Gustafson et al.
NANO TODAY (2015)
Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems
Catherine Ladaviere et al.
NANOMEDICINE (2015)
Latent Mycobacterium tuberculosis Infection
Haileyesus Getahun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cutaneous tuberculosis overview and current treatment regimens
Lindi van Zyl et al.
TUBERCULOSIS (2015)
Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models
Kata Horvati et al.
TUBERCULOSIS (2015)
The where, when, how, and why of hyaluronan binding by immune cells
Sally S. M. Lee-Sayer et al.
FRONTIERS IN IMMUNOLOGY (2015)
Scavenger Receptor Structure and Function in Health and Disease
Izma Abdul Zani et al.
CELLS (2015)
Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety
Mohammed Shafik El-Ridy et al.
DRUG DELIVERY (2015)
Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery
Xu Song et al.
PHARMACEUTICAL RESEARCH (2015)
Nanoparticles as Drug Delivery System against Tuberculosis in Zebrafish Embryos: Direct Visualization and Treatment
Federico Fenaroli et al.
ACS NANO (2014)
Nanoparticle Encapsulated Lipopeptide Conjugate of Antitubercular Drug Isoniazid: In Vitro Intracellular Activity and in Vivo Efficacy in a Guinea Pig Model of Tuberculosis
Kata Horvati et al.
BIOCONJUGATE CHEMISTRY (2014)
Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug-Drug Interactions with Rifamycins
Mario Regazzi et al.
CLINICAL PHARMACOKINETICS (2014)
Early clearance of Mycobacterium tuberculosis: a new frontier in prevention
Ayesha J. Verrall et al.
IMMUNOLOGY (2014)
Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis
Shabir Ahmad Mir et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Optimal structural design of mannosylated nanocarriers for macrophage targeting
Peiming Chen et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites
Yao Qin et al.
JOURNAL OF DRUG TARGETING (2014)
The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy
Ninell P. Mortensen et al.
JOURNAL OF MICROENCAPSULATION (2014)
Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery
Chetna Dhand et al.
RSC ADVANCES (2014)
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
Keertan Dheda et al.
LANCET RESPIRATORY MEDICINE (2014)
Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that Facilitate Nanotechnology
Kim E. Sapsford et al.
CHEMICAL REVIEWS (2013)
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Ernest A. Azzopardi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Hydrolyzed Galactomannan-Modified Nanoparticles and Flower-Like Polymeric Micelles for the Active Targeting of Rifampicin to Macrophages
Marcela A. Moretton et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes
Raja Kalluru et al.
JOURNAL OF CELL SCIENCE (2013)
Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers
Suzanne M. D'Addio et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Molecular biology for formyl peptide receptors in human diseases
Yongsheng Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis
Anthony J. Hickey et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections
Pavan Puligujja et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Stimuli-responsive nanocarriers for drug delivery
Simona Mura et al.
NATURE MATERIALS (2013)
Tuberculosis Pathogenesis and Immunity
Jennifer A. Philips et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
Daniel L. Clemens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Enhanced Cellular Uptake of a New, in Silico Identified Antitubercular Candidate by Peptide Conjugation
Kata Horvati et al.
BIOCONJUGATE CHEMISTRY (2012)
Cellular and Humoral Mechanisms Involved in the Control of Tuberculosis
Joaquin Zuniga et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Particulate Systems for Targeting of Macrophages: Basic and Therapeutic Concepts
S. M. Moghimi et al.
JOURNAL OF INNATE IMMUNITY (2012)
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery
Deepak Singodia et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Biomolecular coronas provide the biological identity of nanosized materials
Marco P. Monopoli et al.
NATURE NANOTECHNOLOGY (2012)
Revisiting the role of the granuloma in tuberculosis
Lalita Ramakrishnan
NATURE REVIEWS IMMUNOLOGY (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Fate of polymeric nanocarriers for oral drug delivery
Laurence Plapied et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2011)
Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis
Gaurav Kumar et al.
DRUG DELIVERY (2011)
Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis
Gaurav Kant Saraogi et al.
JOURNAL OF DRUG TARGETING (2011)
In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis
Gaurav Kumar et al.
JOURNAL OF MICROENCAPSULATION (2011)
Hyaluronan as an Immune Regulator in Human Diseases
Dianhua Jiang et al.
PHYSIOLOGICAL REVIEWS (2011)
Targeted Liposomal Drug Delivery to Monocytes andMacrophages
Ciara Kelly et al.
JOURNAL OF DRUG DELIVERY (2011)
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs
Simi Gunaseelan et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Receptor Specific Macrophage Targeting by Mannose-Conjugated Gelatin Nanoparticles- An In Vitro and In Vivo Study
Shveta Mahajan et al.
CURRENT NANOSCIENCE (2010)
Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages
Sumio Chono et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Mi-Jeong Kim et al.
EMBO MOLECULAR MEDICINE (2010)
Nanobead-based interventions for the treatment and prevention of tuberculosis
Gareth Griffiths et al.
NATURE REVIEWS MICROBIOLOGY (2010)
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages
Wei Xia et al.
BLOOD (2009)
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting
Navneet Nimje et al.
JOURNAL OF DRUG TARGETING (2009)
Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion
Enxian Lu et al.
JOURNAL OF MICROENCAPSULATION (2009)
Mycobacteria Exploit Host Hyaluronan for Efficient Extracellular Replication
Yukio Hirayama et al.
PLOS PATHOGENS (2009)
Neuropilins: structure, function and role in disease
Caroline Pellet-Many et al.
BIOCHEMICAL JOURNAL (2008)
Insights into early mycobacterial pathogenesis from the zebrafish
Robin Lesley et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis
S. M. Hwang et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats
Wassana Wijagkanalan et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Scavenger receptors clear the air
Edward M. Postlethwait
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor
MA von Wronski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis
PB Kang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
A Zahoor et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
R Pandey et al.
TUBERCULOSIS (2005)
Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence
G Mezö et al.
BIOPOLYMERS (2004)
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
SP Vyas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis
JC Leemans et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan
N Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The many faces of host responses to tuberculosis
HL Collins et al.
IMMUNOLOGY (2001)
Tuftsin-bearing liposomes in treatment of macrophage-based infections
AK Agrawal et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
分享论文
